With no approved treatment and growing patient population nonalcoholic steatohepatitis (NASH) is a huge unmet medical need.
NASH Summit Europe is Europe’s definitive forum which exists to solve the challenges drug developers face from discovery to late stage clinical development. This comprehensive forum will help you identify and validate novel targets, better recapitulate human NASH disease preclinically and robustly diagnose patient populations.
With a specific focus on the most pressing drug development challenges this NASH Europe conference will dive into a greater depth of content than any other meeting, ensuring you leave bursting with insights, ideas and solutions to propel your NASH pipeline forward.
Join your peers at NASH Summit Europe to learn from and engage with leading experts and accelerate your NASH drug candidate development.
“Strong program, great speakers and a genuine focus on identifying solutions” Novartis - Previous Hanson Wade Life Sciences event attendee
“This conference was of outstanding value. First class presentations, great opportunity for networking and perfect logistics!” AstraZeneca – Previous Hanson Wade Life Sciences event attendee
“Excellent meeting. Great opportunity for discussions between academia, small start ups, large pharma and regulatory authorities” Merck – Previous Hanson Wade Life Sciences event attendee